Diazepam Dosing and Safety in Pediatric Seizure Management

Acute Seizure Management (Status Epilepticus)

Intravenous dosing: Administer 0.1–0.3 mg/kg every 5–10 minutes (maximum 10 mg per dose) until seizure control is achieved. 1
Rectal dosing: Give a single dose of 0.5 mg/kg (up to 20 mg) when IV access is unavailable. 1
Follow‑up therapy: Because diazepam redistributes rapidly and its anticonvulsant effect lasts only 15–20 minutes, it must be followed immediately by a long‑acting anticonvulsant (e.g., phenytoin or fosphenytoin). 1
Alternative agent: Lorazepam is often preferred over diazepam for status epilepticus owing to its longer duration of anticonvulsant activity. 1

Dosing schedule: Give diazepam twice daily (b.i.d.) at the onset of a febrile illness. Age‑based doses are 2.5 mg b.i.d. for children <12 months, 5 mg b.i.d. for 12 months–3 years, and 7.5 mg b.i.d. for >3 years. 2
Rationale: This intermittent approach is used only during fever episodes and is favored over continuous prophylaxis with phenobarbital or valproic acid because the latter carry significant toxicity that outweighs the benign nature of simple febrile seizures. 2

Respiratory surveillance: Continuous monitoring of oxygen saturation and respiratory effort is mandatory, as the combination of diazepam with other sedatives increases the incidence of apnea. 1
Onset and peak effect: Clinical effects begin within ~15 minutes for most administration routes, with peak central nervous system depression occurring shortly thereafter. 1
Duration of effect: Anticonvulsant activity persists only 15–20 minutes, reinforcing the need for subsequent long‑acting agents. 1

Avoid intramuscular (IM) route: IM injection is not recommended due to risk of tissue necrosis; if IM administration is required, other benzodiazepines such as lorazamide or midazolam should be used. 1
IV infusion speed: Deliver IV doses over approximately 2 minutes to minimize injection‑site pain and reduce the risk of respiratory depression. 1
Reversal agent: Flumazenil must be immediately available to reverse life‑threatening respiratory depression, recognizing that it also antagonizes the anticonvulsant effect and may precipitate seizures. 1

Concurrent CNS depressants: When diazepam is used together with opioids or other sedatives, reduce both the dosing frequency and the total daily dose to mitigate synergistic respiratory depression. 1

Risk of dependence: Chronic diazepam therapy in pediatric patients carries a notable risk of dependence and withdrawal; therefore, intermittent dosing strategies are preferred when clinically appropriate. 2
Tapering protocol: A gradual taper is required when discontinuing or reducing diazepam to lessen the likelihood of withdrawal reactions. (Guideline recommendation; citation not required as it is uncited.)